Cellectis (CLLS) Cash & Equivalents: 2013-2022
Historic Revenue - Interest and Investment Income for Cellectis (CLLS) over the last 7 years, with Dec 2022 value amounting to $261.2 million.
- Cellectis' Revenue - Interest and Investment Income fell 24.99% to $209.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $711.2 million, marking a year-over-year decrease of 27.79%. This contributed to the annual value of $261.2 million for FY2022, which is 31.63% down from last year.
- Per Cellectis' latest filing, its Revenue - Interest and Investment Income stood at $261.2 million for FY2022, which was down 31.63% from $382.1 million recorded in FY2021.
- In the past 5 years, Cellectis' Cash & Equivalents registered a high of $451.5 million during FY2018, and its lowest value of $3.4 million during FY2022.
- For the 3-year period, Cellectis' Cash & Equivalents averaged around $86.1 million, with its median value being $13.8 million (2021).
- As far as peak fluctuations go, Cellectis' Revenue - Interest and Investment Income soared by 50.46% in 2018, and later slumped by 31.63% in 2022.
- Cellectis' Revenue - Interest and Investment Income (Yearly) stood at $500.8 million in 2018, then reached $469.5 million in 2020, then dropped by 18.62% to $382.1 million in 2021, then crashed by 31.63% to $261.2 million in 2022.